{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T21:06:22Z","timestamp":1767992782507,"version":"3.49.0"},"reference-count":59,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,2,22]],"date-time":"2019-02-22T00:00:00Z","timestamp":1550793600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100010665","name":"H2020 Marie Sk\u0142odowska-Curie Actions","doi-asserted-by":"publisher","award":["642720"],"award-info":[{"award-number":["642720"]}],"id":[{"id":"10.13039\/100010665","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arthritis Res Ther"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1186\/s13075-019-1819-9","type":"journal-article","created":{"date-parts":[[2019,2,22]],"date-time":"2019-02-22T14:04:50Z","timestamp":1550844290000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["Combining naproxen and a dual amylin and calcitonin receptor agonist improves pain and structural outcomes in the collagen-induced arthritis rat model"],"prefix":"10.1186","volume":"21","author":[{"given":"Anna","family":"Katri","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aneta","family":"D\u0105browska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Henrik","family":"L\u00f6fvall","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ming","family":"Ding","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Morten A.","family":"Karsdal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kim V.","family":"Andreassen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christian S.","family":"Thudium","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kim","family":"Henriksen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,2,22]]},"reference":[{"key":"1819_CR1","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1038\/nature01661","volume":"423","author":"GS Firestein","year":"2003","unstructured":"Firestein GS. Evolving concepts of rheumatoid arthritis. Nature. 2003;423:356\u201361.","journal-title":"Nature"},{"key":"1819_CR2","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1038\/nature01654","volume":"423","author":"G Karsenty","year":"2003","unstructured":"Karsenty G. The complexities of skeletal biology. Nature. 2003;423:316\u20138.","journal-title":"Nature"},{"key":"1819_CR3","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1136\/ard.59.10.805","volume":"59","author":"TK Kvien","year":"2000","unstructured":"Kvien TK, Haugeberg G, Uhlig T, Falch JA, Halse JI, Lems WF, et al. Data driven attempt to create a clinical algorithm for identification of women with rheumatoid arthritis at high risk of osteoporosis. Ann Rheum Dis. 2000;59:805\u201311.","journal-title":"Ann Rheum Dis"},{"key":"1819_CR4","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1136\/bmj.306.6877.558","volume":"306","author":"TD Spector","year":"1993","unstructured":"Spector TD, Hall GM, McCloskey EV, Kanis JA. Risk of vertebral fracture in women with rheumatoid arthritis. BMJ. 1993;306:558.","journal-title":"BMJ"},{"key":"1819_CR5","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1093\/rheumatology\/30.2.82","volume":"30","author":"AD Woolf","year":"1991","unstructured":"Woolf AD. Osteoporosis in rheumatoid arthritis\u2014the clinical viewpoint. Br J Rheumatol. 1991;30:82\u20134.","journal-title":"Br J Rheumatol"},{"key":"1819_CR6","doi-asserted-by":"publisher","first-page":"1242","DOI":"10.2174\/138161208799316375","volume":"14","author":"D Lorton","year":"2008","unstructured":"Lorton D, Lubahn CL, Zautra AJ, Bellinger DL. Proinflammatory cytokines and sickness behavior in rheumatic diseases. Curr Pharm Des. 2008;14:1242\u201360.","journal-title":"Curr Pharm Des"},{"key":"1819_CR7","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/S0889-857X(21)00853-X","volume":"13","author":"JD Levine","year":"1987","unstructured":"Levine JD, Goetzl EJ, Basbaum AI. Contribution of the nervous system to the pathophysiology of rheumatoid arthritis and other polyarthritides. Rheum Dis Clin N Am. 1987;13:369\u201383.","journal-title":"Rheum Dis Clin N Am"},{"key":"1819_CR8","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1002\/art.10515","volume":"47","author":"T Heiberg","year":"2002","unstructured":"Heiberg T, Kvien TK. Preferences for improved health examined in 1,024 patients with rheumatoid arthritis: pain has highest priority. Arthritis Rheum. 2002;47:391\u20137.","journal-title":"Arthritis Rheum"},{"key":"1819_CR9","doi-asserted-by":"publisher","first-page":"1213","DOI":"10.1177\/147323001003800402","volume":"38","author":"P Taylor","year":"2010","unstructured":"Taylor P, Manger B, Alvaro-Gracia J, Johnstone R, Gomez-Reino J, Eberhardt E, et al. Patient perceptions concerning pain management in the treatment of rheumatoid arthritis. J Int Med Res. 2010;38:1213\u201324.","journal-title":"J Int Med Res"},{"key":"1819_CR10","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1038\/nrd1109","volume":"2","author":"JS Smolen","year":"2003","unstructured":"Smolen JS, Steiner G. Therapeutic strategies for rheumatoid arthritis. Nat Rev Drug Discov. 2003;2:473\u201388.","journal-title":"Nat Rev Drug Discov"},{"key":"1819_CR11","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1016\/S0140-6736(10)60826-4","volume":"376","author":"DL Scott","year":"2010","unstructured":"Scott DL, Wolfe F, Huizinga TWJ. Rheumatoid arthritis. Lancet. 2010;376:1094\u2013108.","journal-title":"Lancet"},{"key":"1819_CR12","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1093\/rheumatology\/kes305","volume":"52","author":"J Listing","year":"2013","unstructured":"Listing J, Gerhold K, Zink A. The risk of infections associated with rheumatoid arthritis, with its comorbidity and treatment. Rheumatology. 2013;52:53\u201361.","journal-title":"Rheumatology"},{"key":"1819_CR13","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1186\/ar2669","volume":"11","author":"SE Gabriel","year":"2009","unstructured":"Gabriel SE, Michaud K. Epidemiological studies in incidence, prevalence, mortality, and comorbidity of the rheumatic diseases. Arthritis Res Ther. 2009;11:229.","journal-title":"Arthritis Res Ther"},{"key":"1819_CR14","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1124\/mol.56.1.235","volume":"56","author":"G Christopoulos","year":"1999","unstructured":"Christopoulos G, Perry KJ, Morfis M, Tilakaratne N, Gao Y, Fraser NJ, et al. Multiple amylin receptors arise from receptor activity-modifying protein interaction with the calcitonin receptor gene product. Mol Pharmacol. 1999;56:235\u201342.","journal-title":"Mol Pharmacol"},{"key":"1819_CR15","doi-asserted-by":"publisher","first-page":"E821","DOI":"10.1152\/ajpendo.00514.2015","volume":"310","author":"S Gydesen","year":"2016","unstructured":"Gydesen S, Andreassen KV, Hjuler ST, Christensen JM, Karsdal MA, Henriksen K. KBP-088, a novel DACRA with prolonged receptor activation, is superior to davalintide in terms of efficacy on body weight. Am J Physiol Endocrinol Metab. 2016;310:E821\u20137.","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"1819_CR16","doi-asserted-by":"publisher","first-page":"137","DOI":"10.2165\/00063030-200822030-00001","volume":"22","author":"MA Karsdal","year":"2008","unstructured":"Karsdal MA, Henriksen K, Arnold M, Christiansen C. Calcitonin: a drug of the past or for the future? Physiologic inhibition of bone resorption while sustaining osteoclast numbers improves bone quality. BioDrugs. 2008;22:137\u201344.","journal-title":"BioDrugs"},{"key":"1819_CR17","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1002\/1529-0131(199906)42:6<1159::AID-ANR12>3.0.CO;2-Q","volume":"42","author":"DH Manicourt","year":"1999","unstructured":"Manicourt DH, Altman RD, Williams JM, Devogelaer JP, Druetz-Van Egeren A, Lenz ME, et al. Treatment with calcitonin suppresses the responses of bone, cartilage, and synovium in the early stages of canine experimental osteoarthritis and significantly reduces the severity of the cartilage lesions. Arthritis Rheum. 1999;42:1159\u201367.","journal-title":"Arthritis Rheum"},{"key":"1819_CR18","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1016\/j.joca.2004.08.005","volume":"12","author":"H Hajjaji El","year":"2004","unstructured":"El Hajjaji H, Williams JM, Devogelaer J-P, Lenz ME, Thonar EJ-MA, Manicourt D-H. Treatment with calcitonin prevents the net loss of collagen, hyaluronan and proteoglycan aggregates from cartilage in the early stages of canine experimental osteoarthritis. Osteoarthr Cartil. 2004;12:904\u201311.","journal-title":"Osteoarthr Cartil"},{"key":"1819_CR19","doi-asserted-by":"publisher","first-page":"2246","DOI":"10.1210\/endo-129-4-2246","volume":"129","author":"TJ Wronski","year":"1991","unstructured":"Wronski TJ, Yen CF, Burton KW, Mehta RC, Newman PS, Soltis EE, et al. Skeletal effects of calcitonin in ovariectomized rats. Endocrinology. 1991;129:2246\u201350.","journal-title":"Endocrinology"},{"key":"1819_CR20","doi-asserted-by":"publisher","first-page":"2674","DOI":"10.1002\/art.22797","volume":"56","author":"B-C Sondergaard","year":"2007","unstructured":"Sondergaard B-C, Oestergaard S, Christiansen C, Tank\u00f3 LB, Karsdal MA. The effect of oral calcitonin on cartilage turnover and surface erosion in an ovariectomized rat model. Arthritis Rheum. 2007;56:2674\u20138.","journal-title":"Arthritis Rheum"},{"key":"1819_CR21","doi-asserted-by":"publisher","first-page":"e54299","DOI":"10.1371\/journal.pone.0054299","volume":"8","author":"A Al-Kashi","year":"2013","unstructured":"Al-Kashi A, Montero-Melendez T, Moradi-Bidhendi N, Gilligan JP, Mehta N, Perretti M. The calcitonin and glucocorticoids combination: mechanistic insights into their class-effect synergy in experimental arthritis. PLoS One. 2013;8:e54299.","journal-title":"PLoS One"},{"key":"1819_CR22","doi-asserted-by":"publisher","first-page":"80S","DOI":"10.1016\/S8756-3282(02)00701-9","volume":"30","author":"M Azria","year":"2002","unstructured":"Azria M. Possible mechanisms of the analgesic action of calcitonin. Bone. 2002;30:80S\u20133S.","journal-title":"Bone"},{"key":"1819_CR23","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1007\/s007740070026","volume":"18","author":"M Yoshimura","year":"2000","unstructured":"Yoshimura M. Analgesic mechanism of calcitonin. J Bone Miner Metab. 2000;18:230\u20133.","journal-title":"J Bone Miner Metab"},{"key":"1819_CR24","doi-asserted-by":"publisher","first-page":"67S","DOI":"10.1016\/S8756-3282(02)00713-5","volume":"30","author":"C Gennari","year":"2002","unstructured":"Gennari C. Analgesic effect of calcitonin in osteoporosis. Bone. 2002;30:67S\u201370S.","journal-title":"Bone"},{"key":"1819_CR25","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1080\/17453674.1997.11744761","volume":"275","author":"GP Lyritis","year":"1997","unstructured":"Lyritis GP, Paspati I, Karachalios T, Ioakimidis D, Skarantavos G, Lyritis PG. Pain relief from nasal salmon calcitonin in osteoporotic vertebral crush fractures. A double blind, placebo-controlled clinical study. Acta Orthop Scand Suppl. 1997;275:112\u20134.","journal-title":"Acta Orthop Scand Suppl"},{"key":"1819_CR26","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1016\/j.bone.2005.04.032","volume":"37","author":"YZ Bagger","year":"2005","unstructured":"Bagger YZ, Tank\u00f3 LB, Alexandersen P, Karsdal MA, Olson M, Mindeholm L, et al. Oral salmon calcitonin induced suppression of urinary collagen type II degradation in postmenopausal women: a new potential treatment of osteoarthritis. Bone. 2005;37:425\u201330.","journal-title":"Bone"},{"key":"1819_CR27","doi-asserted-by":"publisher","first-page":"3205","DOI":"10.1002\/art.22075","volume":"54","author":"D-H Manicourt","year":"2006","unstructured":"Manicourt D-H, Azria M, Mindeholm L, Thonar EJ-M, Devogelaer J-P. Oral salmon calcitonin reduces Lequesne\u2019s algofunctional index scores and decreases urinary and serum levels of biomarkers of joint metabolism in knee osteoarthritis. Arthritis Rheum. 2006;54:3205\u201311.","journal-title":"Arthritis Rheum"},{"key":"1819_CR28","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1016\/j.joca.2014.12.019","volume":"23","author":"MA Karsdal","year":"2015","unstructured":"Karsdal MA, Byrjalsen I, Alexandersen P, Bihlet A, Andersen JR, Riis BJ, et al. Treatment of symptomatic knee osteoarthritis with oral salmon calcitonin: results from two phase 3 trials. Osteoarthr Cartil. 2015;23:532\u201343.","journal-title":"Osteoarthr Cartil"},{"key":"1819_CR29","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1111\/bph.13723","volume":"174","author":"S Gydesen","year":"2017","unstructured":"Gydesen S, Hjuler ST, Freving Z, Andreassen KV, Sonne N, Hellgren LI, et al. A novel dual amylin and calcitonin receptor agonist, KBP-089, induces weight loss through a reduction in fat, but not lean mass, while improving food preference. Br J Pharmacol. 2017;174:591\u2013602.","journal-title":"Br J Pharmacol"},{"key":"1819_CR30","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1124\/jpet.117.241281","volume":"362","author":"ST Hjuler","year":"2017","unstructured":"Hjuler ST, Gydesen S, Andreassen KV, Karsdal MA, Henriksen K. The dual amylin- and calcitonin-receptor agonist KBP-042 works as adjunct to metformin on fasting hyperglycemia and HbA1c in a rat model of type 2 diabetes. J Pharmacol Exp Ther. 2017;362:24\u201330.","journal-title":"J Pharmacol Exp Ther"},{"key":"1819_CR31","doi-asserted-by":"crossref","unstructured":"Andreassen KV, Feigh M, Hjuler ST, Gydesen S, Henriksen JE, Beck-Nielsen H, et al. A novel oral dual amylin and calcitonin receptor agonist (KBP-042) exerts antiobesity and antidiabetic effects in rats. Am J Physiol Endocrinol Metab. 2014;307:E24\u201333.","DOI":"10.1152\/ajpendo.00121.2014"},{"key":"1819_CR32","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1111\/j.1365-2249.2008.03594.x","volume":"152","author":"RH Nielsen","year":"2008","unstructured":"Nielsen RH, Christiansen C, Stolina M, Karsdal MA. Oestrogen exhibits type II collagen protective effects and attenuates collagen-induced arthritis in rats. Clin Exp Immunol. 2008;152:21\u20137.","journal-title":"Clin Exp Immunol"},{"key":"1819_CR33","volume-title":"European patent specification","author":"M Karsdal","year":"2016","unstructured":"Karsdal M, Henriksen K, Andreassen KV. European patent specification; 2016."},{"key":"1819_CR34","doi-asserted-by":"publisher","first-page":"1712","DOI":"10.1002\/oby.21563","volume":"24","author":"ST Hjuler","year":"2016","unstructured":"Hjuler ST, Gydesen S, Andreassen KV, Pedersen SLKK, Hellgren LI, Karsdal MA, et al. The dual amylin- and calcitonin-receptor agonist KBP-042 increases insulin sensitivity and induces weight loss in rats with obesity. Obesity (Silver Spring). 2016;24:1712\u201322.","journal-title":"Obesity (Silver Spring)"},{"key":"1819_CR35","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1007\/BF01972379","volume":"15","author":"RR Martel","year":"1984","unstructured":"Martel RR, Klicius J, Metcalf G, Rona GA. Comparative effects of long term treatment with etodolac, naproxen and ibuprofen on articular and bone changes associated with adjuvant arthritis in rats. Agents Actions. 1984;15:403\u201312.","journal-title":"Agents Actions."},{"key":"1819_CR36","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/0165-0270(94)90144-9","volume":"53","author":"SR Chaplan","year":"1994","unstructured":"Chaplan SR, Bach FW, Pogrel JW, Chung JM, Yaksh TL. Quantitative assessment of tactile allodynia in the rat paw. J Neurosci Methods. 1994;53:55\u201363.","journal-title":"J Neurosci Methods"},{"key":"1819_CR37","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/j.pain.2004.01.029","volume":"109","author":"SJL Flatters","year":"2004","unstructured":"Flatters SJL, Bennett GJ. Ethosuximide reverses paclitaxel- and vincristine-induced painful peripheral neuropathy. Pain. 2004;109:150\u201361.","journal-title":"Pain"},{"key":"1819_CR38","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1111\/jnc.12730","volume":"130","author":"J Su","year":"2014","unstructured":"Su J, Sandor K, Sk\u00f6ld K, H\u00f6kfelt T, Svensson CI, Kultima K. Identification and quantification of neuropeptides in na\u00efve mouse spinal cord using mass spectrometry reveals [des-Ser1]-cerebellin as a novel modulator of nociception. J Neurochem. 2014;130:199\u2013214.","journal-title":"J Neurochem"},{"key":"1819_CR39","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1002\/j.1532-2149.2013.00359.x","volume":"18","author":"K Rutten","year":"2014","unstructured":"Rutten K, Robens A, Read SJ, Christoph T. Pharmacological validation of a refined burrowing paradigm for prediction of analgesic efficacy in a rat model of sub-chronic knee joint inflammation. Eur J Pain. 2014;18:213\u201322.","journal-title":"Eur J Pain"},{"key":"1819_CR40","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1016\/j.clinbiochem.2010.03.012","volume":"43","author":"N Barascuk","year":"2010","unstructured":"Barascuk N, Veidal SS, Larsen L, Larsen DV, Larsen MR, Wang J, et al. A novel assay for extracellular matrix remodeling associated with liver fibrosis: an enzyme-linked immunosorbent assay (ELISA) for a MMP-9 proteolytically revealed neo-epitope of type III collagen. Clin Biochem. 2010;43:899\u2013904.","journal-title":"Clin Biochem"},{"key":"1819_CR41","first-page":"1932","volume":"8","author":"B Winding","year":"2002","unstructured":"Winding B, NicAmhlaoibh R, Misander H, H\u00f8egh-Andersen P, Andersen TL, Holst-Hansen C, et al. Synthetic matrix metalloproteinase inhibitors inhibit growth of established breast cancer osteolytic lesions and prolong survival in mice. Clin Cancer Res. 2002;8:1932\u20139.","journal-title":"Clin Cancer Res"},{"key":"1819_CR42","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1007\/s00223-007-9093-2","volume":"82","author":"M Ding","year":"2008","unstructured":"Ding M, Danielsen CC, Hvid I. The effects of bone remodeling inhibition by alendronate on three-dimensional microarchitecture of subchondral bone tissues in guinea pig primary osteoarthrosis. Calcif Tissue Int. 2008;82:77\u201386.","journal-title":"Calcif Tissue Int"},{"key":"1819_CR43","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1016\/j.semarthrit.2013.07.008","volume":"43","author":"AC Bay-Jensen","year":"2014","unstructured":"Bay-Jensen AC, Platt A, Byrjalsen I, Vergnoud P, Christiansen C, Karsdal MA. Effect of tocilizumab combined with methotrexate on circulating biomarkers of synovium, cartilage, and bone in the LITHE study. Semin Arthritis Rheum. 2014;43:470\u20138.","journal-title":"Semin Arthritis Rheum"},{"key":"1819_CR44","doi-asserted-by":"crossref","unstructured":"Jaffr\u00e9 B, Watrin A, Loeuille D, Gillet P, Netter P, Laugier P, et al. Effects of antiinflammatory drugs on arthritic cartilage: a high-frequency quantitative ultrasound study in rats. Arthritis Rheum. 2003;48:1594\u2013601.","DOI":"10.1002\/art.11023"},{"key":"1819_CR45","doi-asserted-by":"crossref","unstructured":"Kotake S, Yago T, Kawamoto M, Nanke Y. Effects of NSAIDs on differentiation and function of human and murine osteoclasts - crucial \u201chuman osteoclastology\u201d. Pharmaceuticals (Basel). 2010;3:1394\u2013410.","DOI":"10.3390\/ph3051394"},{"key":"1819_CR46","doi-asserted-by":"publisher","first-page":"3566","DOI":"10.1002\/jnr.21808","volume":"86","author":"T Watanabe","year":"2008","unstructured":"Watanabe T, Ito T, Inoue G, Ohtori S, Kitajo K, Doya H, et al. The p75 receptor is associated with inflammatory thermal hypersensitivity. J Neurosci Res. 2008;86:3566\u201374.","journal-title":"J Neurosci Res"},{"key":"1819_CR47","doi-asserted-by":"publisher","first-page":"15292","DOI":"10.1038\/ncomms15292","volume":"8","author":"MC Marrone","year":"2017","unstructured":"Marrone MC, Morabito A, Giustizieri M, Chiurchi\u00f9 V, Leuti A, Mattioli M, et al. TRPV1 channels are critical brain inflammation detectors and neuropathic pain biomarkers in mice. Nat Commun. 2017;8:15292.","journal-title":"Nat Commun"},{"key":"1819_CR48","doi-asserted-by":"publisher","first-page":"561","DOI":"10.2217\/ijr.09.42","volume":"4","author":"MD Cantley","year":"2009","unstructured":"Cantley MD, Smith MD, Haynes DR. Pathogenic bone loss in rheumatoid arthritis: mechanisms and therapeutic approaches. Int J Clin Rheumtol. 2009;4:561\u201382.","journal-title":"Int J Clin Rheumtol"},{"key":"1819_CR49","doi-asserted-by":"publisher","first-page":"1018","DOI":"10.2353\/ajpath.2007.060830","volume":"170","author":"L Mancini","year":"2007","unstructured":"Mancini L, Paul-Clark MJ, Rosignoli G, Hannon R, Martin JE, Macintyre I, et al. Calcitonin and prednisolone display antagonistic actions on bone and have synergistic effects in experimental arthritis. Am J Pathol. 2007;170:1018\u201327.","journal-title":"Am J Pathol"},{"key":"1819_CR50","doi-asserted-by":"publisher","first-page":"1821","DOI":"10.1359\/JBMR.040609","volume":"19","author":"C Behets","year":"2004","unstructured":"Behets C, Williams JM, Chappard D, Devogelaer J-P, Manicourt D-H. Effects of calcitonin on subchondral trabecular bone changes and on osteoarthritic cartilage lesions after acute anterior cruciate ligament deficiency. J Bone Miner Res. 2004;19:1821\u20136.","journal-title":"J Bone Miner Res"},{"key":"1819_CR51","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1007\/BF02001904","volume":"41","author":"PC Braga","year":"1994","unstructured":"Braga PC. Calcitonin and its antinociceptive activity: animal and human investigations 1975-1992. Agents Actions. 1994;41:121\u201331.","journal-title":"Agents Actions"},{"key":"1819_CR52","doi-asserted-by":"crossref","unstructured":"Bay-Jensen AC, Platt A, Siebuhr AS, Christiansen C, Byrjalsen I, Karsdal MA. Early changes in blood-based joint tissue destruction biomarkers are predictive of response to tocilizumab in the LITHE study. Arthritis Res Ther. 2016;18:13.","DOI":"10.1186\/s13075-015-0913-x"},{"key":"1819_CR53","doi-asserted-by":"crossref","unstructured":"Bay-Jensen AC, Byrjalsen I, Siebuhr AS, Christiansen C, Platt A, Karsdal MA. Serological biomarkers of joint tissue turnover predict tocilizumab response at baseline. J Clin Rheumatol. 2014;20:332\u20135.","DOI":"10.1097\/RHU.0000000000000150"},{"key":"1819_CR54","doi-asserted-by":"crossref","unstructured":"Arends RHGP, Karsdal MA, Verburg KM, West CR, Bay-Jensen AC, Keller DS. Identification of serological biomarker profiles associated with total joint replacement in osteoarthritis patients. Osteoarthr Cartil. 2017;25:866\u201377.","DOI":"10.1016\/j.joca.2017.01.006"},{"key":"1819_CR55","doi-asserted-by":"crossref","unstructured":"Chen S-Y, Wu C-L, Lai M-D, Lin C-C, Yo Y-T, Jou I-M, et al. Amelioration of rat collagen-induced arthritis through CD4+ T cells apoptosis and synovial interleukin-17 reduction by indoleamine 2,3-dioxygenase gene therapy. Hum Gene Ther. 2011;22:145\u201354.","DOI":"10.1089\/hum.2009.217"},{"key":"1819_CR56","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1007\/s12016-015-8522-7","volume":"51","author":"CH Alves","year":"2016","unstructured":"Alves CH, Farrell E, Vis M, Colin EM, Lubberts E. Animal models of bone loss in inflammatory arthritis: from cytokines in the bench to novel treatments for bone loss in the bedside-a comprehensive review. Clin Rev Allergy Immunol. 2016;51:27\u201347.","journal-title":"Clin Rev Allergy Immunol"},{"key":"1819_CR57","doi-asserted-by":"publisher","first-page":"2041","DOI":"10.1002\/art.23490","volume":"58","author":"K Fan","year":"2008","unstructured":"Fan K, Dai J, Wang H, Wei H, Cao Z, Hou S, et al. Treatment of collagen-induced arthritis with an anti-osteopontin monoclonal antibody through promotion of apoptosis of both murine and human activated T cells. Arthritis Rheum. 2008;58:2041\u201352.","journal-title":"Arthritis Rheum"},{"key":"1819_CR58","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.3727\/096368915X687949","volume":"25","author":"K-H Park","year":"2016","unstructured":"Park K-H, Mun CH, Kang M-I, Lee S-W, Lee S-K, Park Y-B. Treatment of collagen-induced arthritis using immune modulatory properties of human mesenchymal stem cells. Cell Transplant. 2016;25:1057\u201372.","journal-title":"Cell Transplant"},{"key":"1819_CR59","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1084\/jem.146.3.857","volume":"146","author":"DE Trentham","year":"1977","unstructured":"Trentham DE, Townes AS, Kang AH. Autoimmunity to type II collagen an experimental model of arthritis. J Exp Med. 1977;146:857\u201368.","journal-title":"J Exp Med"}],"container-title":["Arthritis Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13075-019-1819-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13075-019-1819-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13075-019-1819-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,12]],"date-time":"2022-09-12T11:39:54Z","timestamp":1662982794000},"score":1,"resource":{"primary":{"URL":"https:\/\/arthritis-research.biomedcentral.com\/articles\/10.1186\/s13075-019-1819-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2,22]]},"references-count":59,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["1819"],"URL":"https:\/\/doi.org\/10.1186\/s13075-019-1819-9","relation":{},"ISSN":["1478-6362"],"issn-type":[{"value":"1478-6362","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,2,22]]},"assertion":[{"value":"30 July 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 January 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 February 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All animal experimental procedures were approved by the Animal Welfare Division of the Danish Ministry of Justice under the institutional license issued to Nordic Bioscience (2014-15-0201-00097).","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"AK, MAK, KVA, CST, and KH are employees of Nordic Bioscience A\/S which is a company involved in the discovery and development of biochemical biomarkers and novel therapeutic peptides, including KBPs. HL is a former employee of Nordic Bioscience A\/S. KH, KVA, and MAK hold patents on KBPs. MAK and KH hold stocks in Nordic Bioscience A\/S. AD and MD declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"68"}}